400 HOWARD STREET,
SAN FRANCISCO , CA, 94105
SAN FRANCISCO , CA, 94105
Summary
The fund seeks to provide access to companies with healthcare staples exposure, by investing in companies across any size in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in healthcare equipment and services comp More
Webiste
Directors
Oct 13, 2023- John E. Kerrigan
- Richard L. Fagnani
- Robert S. Kapito
- Drew E. Lawton
- John E. Martinez
- Salim Ramji
- Madhav V. Rajan
- Jane D. Carlin
- Cecilia H. Herbert
Chief Compliance Officer
- Aaron Wasserman
Price
- $ 41.4 ( +0 )
-
Aug 29, 2022Last Close
- Net Assets
-
$38.8M
Sep 27, 2022
- 52-Week High/Low
- $0 - $0
- Expense Ratio
- -
Performance
YTD
0%
3 Year
43%
5 Year
0%
Best
194.75%
2021
Worst
-51.73%
2020
Company Name |
Holding |
UnitedHealth Group Inc | 16.24 % |
Abbott Laboratories | 7.3 % |
Danaher Corp | 4.99 % |
Johnson & Johnson | 4.64 % |
Medtronic PLC | 4.42 % |
Thermo Fisher Scientific Inc | 4.06 % |
Elevance Health Inc | 3.31 % |
CVS Health Corp | 3.29 % |
AbbVie Inc | 3.12 % |
Intuitive Surgical Inc | 3.1 % |
More | 3.1 % |
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IEHS | 0% | 0% | 0% | -9.1% | 194.8% | -51.7% | 22.5% | -42.4% | 33.5% | 15.2% | |
S&P 500 | -8.3% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 0% | 0% | -4.1% | 1.5% | -16.4% | 8.1% | 0% | 0% | 0% | ||||
q2 | 0% | 0% | 0% | -12% | 22.9% | 15.7% | 2.4% | 10.3% | 0% | 0% | ||||
q3 | 0% | 0% | 0% | 7.8% | -3.9% | 90.9% | -2.6% | 13.4% | 0% | 0% | ||||
q4 | 0% | 0% | 0% | 0% | -1.5% | -73.9% | 12.4% | -11.6% | 0% | 0% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |